LDN and Neuroinflammation (Link to Depression/Anxiety) Younger, J., Parkitny, L., & McLain, D
Du L, Qin J, Wang D, et al
Usage & Storage Description Retatrutide is a novel triple receptor agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors simultaneously
Frontiers in Neurolology
While these medications can be helpful tools for weight management, we are seeing a growing concern: patients are unintentionally under-eating before and after surgery out of fear of weight gain, and this can directly affect healing and recovery
Sleep Quality Some patients may first pay attention to sleep consistency, nighttime rest, or how refreshed they feel in the morning